Recent Finacing
Recent Raise
Tolerance Bio develops allogeneic iPSC-derived thymus therapies and pharmacologic thymus modulators to restore or modulate thymic function for immune-mediated diseases like autoimmunity, transplant rejection, cancer, infections, and allergies.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
